Abstract The present study examined plasma lipoprotein, lipoprotein lipase, hepatic lipase, and insulin levels in men with borderline hypertension (diastolic blood pressure 85 to 94 mm Hg) compared with age-matched normotensive control subjects (diastolic blood pressure less than or equal to 80 mmHg, n=75+75). High-density lipoprotein (HDL) subclasses were determinea in a subset (n=45+45). While total and low-density lipoprotein cholesterol levels were similar, levels of very-low-density lipoprotein (VLDL) 3 It has been suggested that insulin resistance with ensuing hyperinsulinemia could be the common link and perhaps even represent the underlying pathogenic mechanism. 4 Insulin stimulates the hepatic secretion of verylow-density lipoprotein (VLDL) and has been implicated in the activation of lipoprotein lipase (LPL), a key enzyme in the regulation of triglyceride-rich lipoproteins in plasma. 5 The dyslipidemia seen in established but untreated hypertension comprises raised plasma levels of total cholesterol, total triglycerides, and low-density lipoprotein (LDL) cholesterol, frequently accompanied by a reduced concentration of high-density lipoprotein (HDL) cholesterol. 6 -8 Many epidemiological studies have shown an independent inverse relationship between HDL and the risk of developing coronary heart disease (CHD it is as yet unclear at which stage in the hypertensive process dyslipoproteinemic changes occur and how they are related to blood pressure, obesity, and other metabolic variables. To elucidate this, one could either perform long-term follow-up studies of a great number of normotensive subjects or undertake case-control studies of hypertensive subjects at an early stage and normotensive control subjects. We have chosen to investigate a population-based group of men with borderline hypertension (BHT) and age-matched normotensive (NT) control subjects from the same population. Our focus was on plasma lipoproteins, postheparin plasma LPL and HL activities, insulin levels, and anthropometric data.
S everal cardiovascular risk factors aggregate in pa-
tients with essential hypertension, such as dyslipidemia, glucose intolerance, and hyperinsulinemia. 1 
"
3 It has been suggested that insulin resistance with ensuing hyperinsulinemia could be the common link and perhaps even represent the underlying pathogenic mechanism. 4 Insulin stimulates the hepatic secretion of verylow-density lipoprotein (VLDL) and has been implicated in the activation of lipoprotein lipase (LPL), a key enzyme in the regulation of triglyceride-rich lipoproteins in plasma. 5 The dyslipidemia seen in established but untreated hypertension comprises raised plasma levels of total cholesterol, total triglycerides, and low-density lipoprotein (LDL) cholesterol, frequently accompanied by a reduced concentration of high-density lipoprotein (HDL) cholesterol. 6 -8 Many epidemiological studies have shown an independent inverse relationship between HDL and the risk of developing coronary heart disease (CHD). 911 Furthermore, it has been shown that this inverse relationship between HDL cholesterol and CHD is mainly due to the HDL subclass HDL 2 , 1213 while the HDL gradient gel electrophoresis (GGE) subclass HDL3 b correlates positively with the progression of coronary atherosclerosis. 14 The factors that regulate the concentrations of the different HDL subclasses are not fully elucidated, but LPL and hepatic lipase (HL) appear to be involved in a reciprocal manner.
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Although some evidence indicates the presence of metabolic disturbances in prehypertensive individuals, 17 it is as yet unclear at which stage in the hypertensive process dyslipoproteinemic changes occur and how they are related to blood pressure, obesity, and other metabolic variables. To elucidate this, one could either perform long-term follow-up studies of a great number of normotensive subjects or undertake case-control studies of hypertensive subjects at an early stage and normotensive control subjects. We have chosen to investigate a population-based group of men with borderline hypertension (BHT) and age-matched normotensive (NT) control subjects from the same population. Our focus was on plasma lipoproteins, postheparin plasma LPL and HL activities, insulin levels, and anthropometric data.
Methods

Study Groups
In 1985, a blood pressure screening program was started in Akersberga, a small community 80 km north of Stockholm. All men aged 35 to 55 years were asked by mail to visit the primary health care center and have their blood pressure measured. Indiviuals with a diastolic blood pressure (DBP) greater than or equal to 85 mm Hg were tested repeatedly on three different occasions of at least 1 week apart. From a sample of 2694 people, a total of 207 individuals had a DBP of 85 to 94 mm Hg on all three occasions and were classified as BHT. Of these, 14 declined further participation, leaving a group of 193 subjects. The 193 subjects were followed with yearly follow-up visits for 3 years. At these follow-ups, approximately 20% of the subjects had become hypertensive and 20% had become normotensive, with the major change (13% to 15%) occurring already at the 1-year follow-up visit. After 3 years, 81 men were still within the range for BHT on the basis of repeated measurements over the entire time period.
These 81 individuals with BHT were invited to participate in the present investigation together with 80 age-matched male control subjects from the original population who had a DBP less than or equal to 80 mm Hg at the initial measurement. To obtain 80 age-matched control subjects, 105 normotensive men were asked to participate; 23 declined participation and 2 had a DBP greater than 80 mm Hg. The blood pressure of the control subjects was measured on two occasions a few weeks apart. To participate in the study, the subjects' DBP should have been less than or equal to 80 mm Hg on both occasions. All blood pressure measurements during the entire recruitment procedure and study period were performed by the same person, a specially trained nurse.
The study was approved by the local Ethics Committee of Karolinska Hospital and conducted in accordance with the Helsinki Declaration. All subjects gave their informed consent before entering the study. Of the 81 men with BHT and the 80 NT control subjects who agreed to participate in the study, 2 subjects in the BHT group discontinued the study program. One died (malignancy) and another moved overseas. Four of the patients did not complete all tests. One NT subject had insulin-dependent diabetes mellitus and could not complete the study. As in the BHT group, 4 NT individuals did not complete all tests. Data for these individuals have been excluded. None of the subjects had any other illnesses or were using any drugs known to influence blood pressure or lipoproteins.
Study Program
All subjects were investigated according to the same schedule. Men with BHT and their control counterparts were investigated simultaneously when possible and no more than 4 weeks apart. Blood samples for lipoprotein analyses and basal insulin and glucose determinations were taken between 8 and 9:30 AM, after 8 to 12 hours of fasting. All samples were drawn after 15 minutes of rest with subjects in the supine position. For determination of VLDL, LDL, and HDL, blood was allowed to clot for 2 hours at room temperature, and serum was then recovered for ultracentrifugation by low-speed centrifugation (1400g for 20 minutes at +20°C). A subset of 45 pairs of hypertensive and control subjects was randomly selected for additional HDL subclass determination. Venous blood was drawn into precooled tubes containing Na 2 EDTA, placed in ice water, and centrifuged at 1400g for 20 minutes at + 1°C.
Lipoprotein Determinations
The major plasma lipoproteins were determined by a combination of preparative ultracentrifugation and precipitation of lipoproteins containing apolipoprotein B (apoB) followed by lipid analyses in the lipoprotein fractions, as previously described. 18 HDL subclasses were determined by a previously described modification 19 of the GGE method described by Blanche et al. 20 Briefly, albumin-free HDL was separated from plasma by two consecutive ultracentrifugations in an L8-55 ultracentrifuge (Beckman Instruments) equipped with a 50-Ti fixed-angle rotor for 20 and 65 hours, respectively, at +1°C. Within 24 hours of the separation, HDL GGE was performed, using a polyacrylamide gradient gel (PAA 4/30, Pharmacia). The gels were scanned at 570 nm (CS930 dual scanner, Shimadzu Corp) after 16 hours of electrophoresis and staining with Amido black. The relative distribution of HDL between the major subclasses HDLj,, HDL^, HDL, a , HDL,,,, and HDLfc was calculated by delineating the area under the protein curve for each subclass, weighing the cutout areas, and relating their respective weights to the weight of the area corresponding to the entire HDL distribution. The relative area was then multiplied with the plasma HDL protein concentration to give the concentration of the respective subclass. ApoB was measured by radioimmunoassay (RIA apoB, Kabi Pharmacia).
LPL and HL activities in postheparin plasma were measured in plasma drawn 15 minutes after the injection of heparin (50 U/kg body wt) using sonicated [ 3 H]trioleoyl-glycerol emulsions stabilized by phosphatidylcholine as substrates. 21 Lipase activities were expressed as milliunits per milliliter, which corresponds to 1 nmol of fatty acid released per minute.
Insulin and Glucose Assays
Basal plasma insulin was measured by RIA (Kabi Pharmacia); blood glucose was determined with a glucose oxidase method (Kodak Ectachem).
Blood Pressure Measurements
An identical procedure was followed at each occasion during the entire recruitment period. All blood pressure measurements were performed with a mercury sphygmomanometer. The cuff was adjusted according to the circumference of the arm and placed at the level of the heart. Blood pressure was recorded as the mean of two measurements taken after 5 minutes of rest with subjects in the supine position. Systolic blood pressure and DBP were defined according to Korotkoff phases I and V. The same specially trained nurse performed the measurements at all occasions.
Body Stature
All patients were weighed wearing only underwear, using the same scale (Delta 707, SECA). Height was measured with a special ruler fixed to the wall. Waist circumference was measured at the level of the umbilicus, and the hips were measured at the level of the greatest circumference. Body mass index (BMI) was subsequently calculated as weight in kilograms divided by height in meters squared.
Dietary History
Dietary habits were investigated in a subset of 62 randomly selected people (31 pairs of cases and control subjects). Food intake was recorded with the use of a specially constructed food diary developed by the National Food Administration and used in the nationwide Household Food Survey in Sweden in 1989. 22 The diary covers 1 week and contains a set of preprinted alternatives to choose from for each meal and sections for any additional food intake. The amount of food is also noted, using visual comparison with standard portion sizes. The results from the diary are then computerized for estimation of the intake of energy, fiber, carbohydrates, saturated and unsaturated fats, minerals, and vitamins.
Statistical Methods
Variables were tested for skewness. For skewed variables, nonparametric tests were used for comparisons between the groups (Mann-Whitney U test), and Student's t test was used for normally distributed variables. Categorical variables were compared using the x 2 test. Spearman rank correlation coefficients were calculated to estimate interrelations among plasma lipoproteins, insulin, clinical characteristics, and groups. AN-COVA was performed to control for the confounding effects of differences in BMI and insulin levels between the groups. Stepwise discriminant analysis was performed to determine which variables provided the best discrimination between BHT men and control subjects. The variable with the highest F value was entered at each step until no variable remained with an F value (F-to-enter) of 4 or more. Skewed variables were lognormalized before they were subjected to ANCOVA and discriminant analysis. The significance level was put at a value of P<.05. Because many statistical calculations were performed, findings with a value of P<.01 were interpreted with caution. Values in the text are given as mean±SD. .022
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Values are mean±SD or percentage of the total group. Group differences were determined by Student's f test or Mann-Whitney U test (skewed variables).
Results
Characteristics of Cases and Control Subjects
Basic characteristics of the two study groups are presented in Table 1 . The two groups were well matched for age. Blood pressure levels in the two groups were clearly different from each other (mean: NT, 125/75 mm Hg; BHT, 141/89 mm Hg). The BHT group had a significantly higher BMI with a somewhat more pronounced central obesity, as evidenced by a slightly but significantly higher waist-hip ratio. Both groups, however, were below the recommended waisthip ratio of 1.0.
Apart from a significantly higher hemoglobin level and a higher red blood cell count in the BHT group (4.6+0.04 versus 4.7±0.04Xl0 12 per liter, P=.O42), routine laboratory test results were similar in the two groups. The fasting blood glucose level was similar in the two groups, whereas men with BHT had a significantly higher basal insulin level (17.2±5.9 versus 14.2±4.7 /xU/mL, P=.0
Major Plasma Lipoproteins
The plasma concentrations of total triglycerides, VLDL triglycerides, and VLDL cholesterol were significantly elevated in the men with BHT, whereas the HDL cholesterol level was significantly reduced. In contrast, plasma cholesterol, LDL cholesterol, LDL triglycerides, and plasma apoB were similar in the two groups (Table 2) .
When the group differences in BMI and insulin were taken into account in ANCOVA, differences between the two groups in plasma lipoproteins disappeared (F<1.7, P>.20, data not shown).
HDL Subclasses
The plasma HDL 2b protein concentration was significantly lower in the BHT group than in the NT group, whereas HDL 3b and HDL 3c protein concentrations were significantly higher. Plasma protein concentrations of HDL 2a and HDL 3a were similar in the two groups (Table 3) .
When adjusted for BMI or plasma insulin level, HDL3 b and HDL) C concentrations remained significantly higher (F=7.69, P=W1, df=l; and F=5.52, P=.O21, df=l, respectively). In contrast, the H D L a concentration was no longer significantly lower (F=3.49, ,P=.O66, df=l). 20 Values are mean±SD. Group differences were determined by Mann-Whitney U test. *HDL measurements failed in three subjects.
Postheparin Plasma Lipoprotein and HL Activities LPL activity was similar in the two groups (BHT, 84.3±4.3 mU/mL; NT, 85.2±4.8 mU/mL), whereas HL activity was significantly elevated in the BHT group (281.8±16.0 versus 232.1±14.8 mU/mL, P=.O24).
LPL was negatively correlated to plasma insulin in the BHT group alone (r=-.27, P=.O22) and exhibited strong negative correlations in both the BHT and NT groups to VLDL cholesterol (r=-.47, P=.001 and r = -. 3 3 , P=.OO5), total triglyceride (r=-A6, P=.001 and r=-.36, P=.002), and VLDL triglyceride (r=-.5O, P=.001 and r=-.39, P=.0009) concentrations. There was also a positive correlation of LPL with HDL cholesterol levels in both groups (r=.32, P=.OO6 and r=.23, P=.O49).
HL correlated with basal insulin levels but only in the NT group (r=.27, P=.O23) and the combined groups (r=.26, P=.O21). There were no significant correlations between HL and concentrations of lipoprotein fractions except for a negative correlation to HDL triglycerides (r=-.27, i>=.016 and r=-.21, / > =.018). There were no correlations between HL and the HDL GGE subclasses.
There was a positive correlation between HL and BMI in the NT group (r=.28, P=.015), but there were no other correlations between LPL and HL activity and BMI or waist-hip ratio in the two groups.
Dietary Habits
Of the 62 people selected, 1 in each group failed to complete the diary. There were no significant differences between the BHT and NT groups in daily energy intake (8370 ±1680 versus 8988 ±1751 kJ) and intake of fat (81 ±19 versus 88±20 g), saturated fat (35±7 versus 38±11 g), monounsaturated fat (28±7 versus 31±7 g), polyunsaturated fat (12±3 versus 13±5 g), and cholesterol (382 ±55 versus 346 ±17 g). In addition, there were no significant differences in daily fiber intake (16 ±1 versus 17±1 g), alcohol consumption (12±2 versus 15±2 g), or carbohydrate intake (224±58 versus 234±57 g).
There was a significant correlation between energy intake and waist-hip ratio (r=.34, / ) =.008) but not between energy intake and BMI, whereas the intake of fiber correlated negatively with waist-hip ratio (r= -.33,
P=.04l).
Relations of Plasma Lipoproteins to Age, Blood Pressure, Obesity, and Plasma Insulin
There were no correlations between age and plasma lipoprotein levels. DBP correlated weakly but significantly with plasma triglycerides (r=.17, P=.O4) and HDL 2b (r=-.24, P=.O3) in the two groups combined, but when analyzed separately in the BHT and NT groups, DBP did not correlate with any of the lipoprotein variables (data not shown). Both BMI and waist-hip ratio were correlated to several of the lipid fractions (see Table 4 ). In both groups, there were strong positive correlations between both waist-hip ratio and BMI and VLDL cholesterol, plasma triglycerides, and VLDL triglycerides. In addition, there was a strong negative correlation between both BMI and waist-hip ratio and HDL cholesterol. In the BHT group, BMI and waist-hip ratio correlated positively with plasma apoB levels. Several of the lipoprotein fractions also correlated significantly with the basal insulin levels (Table 4) . Significant positive correlations were thus found in the BHT and NT groups between insulin and the concentrations of VLDL cholesterol, plasma triglycerides, VLDL triglycerides, and plasma apoB. There were also strong negative correlations with the HDL cholesterol level.
In general, there were no correlations between the HDL subclasses and BMI, waist-hip ratio, or insulin, except for HDL 2b , which correlated negatively to BMI, waist-hip ratio, and insulin in the NT group alone (r=-.35, P=.O43; r=-.30, P=.O38; and r=-.43,
P=.OO8, respectively).
Taking into account the fact that the plasma insulin level also correlated strongly with both waist-hip ratio and BMI (r=.38, P=.0001 and r=.51, P=.0001, respectively), the similar relations of BMI, waist-hip ratio, and insulin to plasma lipoproteins are not surprising.
Discriminant Analysis
In a stepwise discriminant analysis, the basal insulin level emerged as the most discriminating variable (F= 18.41, df =1/132). Other significant discriminators were BMI (F=8.50), waist-hip ratio (F=6.85), plasma triglycerides (F=6.44), VLDL triglycerides (F=6.28), and HDL cholesterol (F=4.85). With basal insulin levels entered into the equation, no other variable contributed significantly to the discrimination between the two groups. However, basal insulin levels provided a correct classification in no more than 64% of the subjects, indicating that other factors not recorded or entered into the equation have a considerable impact.
Discussion
Several studies in established hypertension have shown a pattern of fasting hyperinsulinemia, decreased HDL cholesterol concentrations, and increased levels of total and VLDL triglycerides.
8 - 23 Our findings confirm the findings of the San Antonio Heart Study, 17 showing a similar pattern in BHT, ie, at an early stage of the hypertensive process. In addition, our study shows that the HDL particle distribution is skewed to the left in the BHT group, with increases in the concentrations of the smaller HDL3 b and HDL^ particles coupled with a decreased level of the larger H D L a particles. Because decreased HDL 2b and increased HDLjb concentrations have been shown to be associated with the progression of coronary atherosclerosis in post-myocardial infarction, 1214 these disturbances in the HDL profile might contribute to the increased rate of cardiovascular disease reported in BHT. 24 Both age and BMI were adjusted for in several case-control studies of hypertension. 6 - 25 On the assumption that ponderosity as such could be an important factor, we chose not to match the subjects for BMI. It is noteworthy that there was indeed a significant difference in BMI between the two groups. Furthermore, most of the above group differences in plasma lipoproteins disappear when adjustments for BMI or insulin are made. It could thus be speculated that the dyslipoproteinemia seen in hypertensive men could be a result of obesity rather than of an inherent metabolic dysfunction. Interestingly, HDL subclasses seemed to be less influenced by BMI and insulin. The differences between the BHT and NT groups in levels of HDL31, and HDL^ remained also when differences in BMI and insulin were taken into account. This raises several interesting possibilities, including that there might already be a disturbance in the HDL metabolism in the early hypertensive stage that is independent of obesity and hyperinsulinemia.
Even though no significant correlations could be found in this study between HL and HDL GGE subclasses, it is not unlikely that the significantly higher HL activity in the BHT group could have contributed to the lower HDLa, and higher HDL^ concentrations observed among the men in that group, because HL has a role in converting HDL 2 to HDL, through lipolysis of the HDL 2 triglyceride content. 26 The LPL activity did not differ between the groups, indicating that the higher VLDL levels in the men with BHT were largely due to an elevated VLDL production rate from the liver, not to a decreased VLDL clearance. However, the significant correlations of LPL with the levels of VLDL and HDL cholesterol as well as with VLDL, HDL, and total triglyceride concentrations also implicate LPL activity as a possible factor contributing to the observed differences in lipoprotein patterns.
Because dietary habits could influence several metabolic variables, 27 -28 the food intake of the subjects was investigated. We can conclude that the observed lipoprotein changes are not the result of widely varying dietary habits. In fact, there were no significant differences at all in the intake or nature of dietary fats. The finding that caloric intake correlates with waist-hip ratio but not with BMI is intriguing. Despite the relatively restricted number of individuals and the inability of the diary method to detect long-term variations in food intake, our data are sufficiently interesting to warrant further investigation in longitudinal studies. It is thus possible that a tendency for centralization of obesity, not dependent on caloric intake alone, develops early in the hypertensive process. However, we cannot infer from this case-control study whether the borderline state precedes the central obesity or vice versa.
What are the implications of the present study? Although a cross-sectional study does not allow for conclusions as to temporal relationships between elevated blood pressure, overweight, hyperinsulinemia, and dyslipoproteinemia, it is nevertheless noteworthy that these disturbances are already present in BHT. In the prospective San Antonio Heart Study, an aggregation of cardiovascular risk factors has been demonstrated in prehypertensive individuals. 17 Our present study confirms this observation and adds further knowledge on the nature of the dyslipidemic changes and contributing factors. The relationship of this Iow-HDL2b and high-HDL3,, pattern to HL activity and insulin resistance, as evidenced by fasting hyperinsulinemia, and the sequence in which these changes occur are worthy of further investigation. The results also indicate that certain lipoprotein disturbances are present independent of overweight and hyperinsulinemia. Because the pattern of low HDL 2 b and elevated HDL3 b concentrations has been implicated in the progression of coronary atherosclerosis, this alteration of the HDL profile could be of importance for the prognosis of the BHT patient.
